The control of the consumer risk in the ames assay

Show simple item record

dc.identifier.uri Neuhäuser, Markus Hothorn, Ludwig A. 2018-03-01T13:28:38Z 2018-03-01T13:28:38Z 1997
dc.identifier.citation Neuhäuser, M.; Hothorn, L.A.: The control of the consumer risk in the ames assay. In: Therapeutic Innovation & Regulatory Science 31 (1997), Nr. 2, S. 363-367. DOI:
dc.description.abstract Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative. © 1997, Drug Information Association. All rights reserved. eng
dc.language.iso eng
dc.publisher London : SAGE Publications Ltd.
dc.relation.ispartofseries Therapeutic Innovation & Regulatory Science 31 (1997), Nr. 2
dc.rights Es gilt deutsches Urheberrecht. Das Dokument darf zum eigenen Gebrauch kostenfrei genutzt, aber nicht im Internet bereitgestellt oder an Außenstehende weitergegeben werden. Dieser Beitrag ist aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
dc.subject Ames assay eng
dc.subject Consumer risk eng
dc.subject Difference approach eng
dc.subject Equivalence test procedures for ordered many-to-one designs eng
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title The control of the consumer risk in the ames assay eng
dc.type Article
dc.type Text
dc.relation.issn 2168-4790
dc.bibliographicCitation.issue 2
dc.bibliographicCitation.volume 31
dc.bibliographicCitation.firstPage 363
dc.bibliographicCitation.lastPage 367
dc.description.version publishedVersion
tib.accessRights frei zug�nglich

Files in this item

This item appears in the following Collection(s):

Show simple item record


Search the repository


My Account

Usage Statistics